NCT00601536View on ClinicalTrials.gov

Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Bipolar Disorder
Interventions
DRUG

Lithium

Trial Locations (1)

15206

Novum Pharmaceutical Research Services, Pittsburgh

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00601536 - Bioequivalency Study of 300 mg Lithium Carbonate Under Fasting Conditions | Biotech Hunter | Biotech Hunter